Related Experiment Video

Updated: Jun 19, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Therapy of community-acquired acute bacterial meningitis: the clock is running

M Klein1, H W Pfister, S L Leib

  • 1Ludwig Maximilians University, Department of Neurology, Klinikum Grosshadern, Marchioninistrasse 15, 83533 Munich, Germany.

Expert Opinion on Pharmacotherapy
|October 16, 2009
PubMed

Insights

Bacterial meningitis is deadly, but quick diagnosis and antibiotic treatment improve outcomes. Prompt medical care, including timely antibiotics, is vital for patient survival and recovery from this serious infection.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Critical Care Medicine

Background:

  • Bacterial meningitis has high mortality and morbidity despite treatment.
  • Early symptom recognition is key for prompt diagnosis and empiric antibiotic therapy.
  • Time to first antibiotic dose is a critical factor influencing patient outcomes.

Purpose of the Study:

  • To review the clinical and laboratory presentation of community-acquired bacterial meningitis.
  • To discuss current recommended antibiotic regimens and future therapeutic options.
  • To provide suggestions for patient management in suspected bacterial meningitis cases.

Main Methods:

  • Literature review of clinical and laboratory findings in bacterial meningitis.
  • Analysis of current antibiotic treatment guidelines.
  • Discussion of emerging therapeutic strategies.
  • Development of a suggested patient management approach.

Main Results:

  • Bacterial meningitis necessitates rapid diagnostic and therapeutic interventions.
  • Timely administration of antibiotics significantly impacts patient prognosis.
  • Current treatment focuses on specific antibiotic regimens based on causative agents.

Conclusions:

  • Early recognition and prompt antibiotic therapy are critical for improving outcomes in bacterial meningitis.
  • A structured approach to patient management is essential for timely and effective care.
  • Ongoing research into future therapeutic options holds promise for further reducing mortality and morbidity.

More Related Videos

Growth of Mycobacterium tuberculosis Biofilms09:03

Growth of Mycobacterium tuberculosis Biofilms

Published on: February 15, 2012

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...